Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update: gastric MALT lymphoma.

Brad S Kahl1

  • 1Department of Medicine, University of Wisconsin, Madison, USA. bsk@medicine.wisc.edu

Current Opinion in Oncology
|September 10, 2003
PubMed
Summary

Gastric MALT lymphoma with an 11:18 translocation shows H. pylori-independent growth and requires different treatment strategies. Understanding its biology improves clinical practice for this malignancy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and Validation of a Novel Conditional Event-Free Survival Tool in Diffuse Large B-Cell Lymphoma.

American journal of hematology·2026
Same author

Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy.

Blood cancer journal·2026
Same author

Diagnosis-to-treatment interval is associated with outcomes in follicular lymphoma treated with immunochemotherapy.

Blood·2026
Same author

Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma.

Blood advances·2026
Same author

Patterns of care and clinical outcomes in systemic peripheral T-cell lymphoma: the LEO-MER prospective cohort study.

Blood advances·2026
Same author

A randomized phase 2 study of ipilimumab, nivolumab, and brentuximab vedotin in patients with relapsed Hodgkin lymphoma.

Blood·2026

Area of Science:

  • Gastroenterology
  • Oncology
  • Molecular Biology

Background:

  • Gastric MALT lymphoma serves as a model for neoplasia development from chronic inflammation.
  • Recent research advances understanding of its pathogenesis, clinical behavior, and treatment.

Purpose of the Study:

  • To review recent advancements in gastric MALT lymphoma (Mucosa-Associated Lymphoid Tissue lymphoma).
  • To highlight the translation of biological insights into improved clinical practice.

Main Methods:

  • Review of recent publications on gastric MALT lymphoma.
  • Analysis of genetic translocations, molecular pathways, and clinical trial data.

Main Results:

  • A significant subset of gastric MALT lymphoma cases harbor an 11:18 translocation, leading to BCL10 activation and NF-kB pathway signaling.
  • This genetic subtype exhibits H. pylori-independent growth, presents with advanced disease, and is less responsive to H. pylori eradication.
  • Paradoxically, the 11:18 translocation subtype is less prone to large-cell transformation but may require cytotoxic therapy.

Conclusions:

  • The pathogenesis of gastric MALT lymphoma is increasingly understood.
  • Biological insights are expected to significantly impact clinical management and treatment strategies.

Related Experiment Videos